Literature DB >> 26380721

Magnetic resonance imaging for staging of non-small-cell lung cancer-technical advances and unmet needs.

Gregor Sommer1, Bram Stieltjes1.   

Abstract

Entities:  

Year:  2015        PMID： 26380721      PMCID： PMC4522472          DOI： 10.3978/j.issn.2072-1439.2015.07.21

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

1.  Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?

Authors:  Lian-Ming Wu; Jian-Rong Xu; Hai-Yan Gu; Jia Hua; Jie Chen; Wei Zhang; E Mark Haacke; Jiani Hu
Journal:  J Surg Res       Date:  2012-04-22       Impact factor: 2.192

2.  N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: initial experience.

Authors:  A A Kohan; J A Kolthammer; J L Vercher-Conejero; C Rubbert; S Partovi; R Jones; K A Herrmann; P Faulhaber
Journal:  Eur Radiol       Date:  2013-06-14       Impact factor: 5.315

3.  Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Takeshi Yoshikawa; Daisuke Takenaka; Shinichiro Seki; Masao Yui; Hitoshi Yamagata; Kota Aoyagi; Sumiaki Matsumoto; Kazuro Sugimura
Journal:  Radiology       Date:  2015-01-14       Impact factor: 11.105

4.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.

Authors:  M K Gould; C C Maclean; W G Kuschner; C E Rydzak; D K Owens
Journal:  JAMA       Date:  2001-02-21       Impact factor: 56.272

5.  Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.

Authors:  Chin A Yi; Kyung Soo Lee; Ho Yun Lee; Seonwoo Kim; O Jung Kwon; Hojoong Kim; Joon Young Choi; Byung-Tae Kim; Hye Sun Hwang; Young Mog Shim
Journal:  Cancer       Date:  2013-02-19       Impact factor: 6.860

6.  Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.

Authors:  Paul De Leyn; Christophe Dooms; Jaroslaw Kuzdzal; Didier Lardinois; Bernward Passlick; Ramon Rami-Porta; Akif Turna; Paul Van Schil; Frederico Venuta; David Waller; Walter Weder; Marcin Zielinski
Journal:  Eur J Cardiothorac Surg       Date:  2014-02-26       Impact factor: 4.191

7.  The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax.

Authors:  Miwa Morikawa; Yoshiki Demura; Takeshi Ishizaki; Shingo Ameshima; Isamu Miyamori; Masato Sasaki; Tatsuro Tsuchida; Hirohiko Kimura; Yasuhisa Fujibayashi; Hidehiko Okazawa
Journal:  J Nucl Med       Date:  2008-12-17       Impact factor: 10.057

8.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.

Authors:  Taro Takahara; Yutaka Imai; Tomohiro Yamashita; Seiei Yasuda; Seiji Nasu; Marc Van Cauteren
Journal:  Radiat Med       Date:  2004 Jul-Aug

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging.

Authors:  Yoshiharu Ohno; Hiroto Hatabu; Daisuke Takenaka; Takanori Higashino; Hirokazu Watanabe; Chiho Ohbayashi; Masahiro Yoshimura; Miyako Satouchi; Yoshihiro Nishimura; Kazuro Sugimura
Journal:  Radiology       Date:  2004-06       Impact factor: 11.105
View more
  3 in total

Review 1.  Magnetic resonance imaging in precision radiation therapy for lung cancer.

Authors:  Hannah Bainbridge; Ahmed Salem; Rob H N Tijssen; Michael Dubec; Andreas Wetscherek; Corinne Van Es; Jose Belderbos; Corinne Faivre-Finn; Fiona McDonald
Journal:  Transl Lung Cancer Res       Date:  2017-12

Review 2.  Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0.

Authors:  Sofia C Vaz; Judit A Adam; Roberto C Delgado Bolton; Pierre Vera; Wouter van Elmpt; Ken Herrmann; Rodney J Hicks; Yolande Lievens; Andrea Santos; Heiko Schöder; Bernard Dubray; Dimitris Visvikis; Esther G C Troost; Lioe-Fee de Geus-Oei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-13       Impact factor: 10.057

Review 3.  Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.

Authors:  Sanjay Popat; Neal Navani; Keith M Kerr; Egbert F Smit; Timothy J P Batchelor; Paul Van Schil; Suresh Senan; Fiona McDonald
Journal:  Oncologist       Date:  2020-11-21       Impact factor: 5.837
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.